DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹611 Cr | ₹557 Cr | ₹437 Cr | ₹364 Cr | ₹295 Cr |
What is the latest Total Non-Current Liabilities ratio of DIVIS LABORATORIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹611 Cr |
Mar2023 | ₹557 Cr |
Mar2022 | ₹437 Cr |
Mar2021 | ₹364 Cr |
Mar2020 | ₹295 Cr |
How is Total Non-Current Liabilities of DIVIS LABORATORIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹611 Cr | 9.69 | |
Mar2023 | ₹557 Cr | 27.60 | |
Mar2022 | ₹437 Cr | 19.94 | |
Mar2021 | ₹364 Cr | 23.55 | |
Mar2020 | ₹295 Cr | - |
Compare Total Non-Current Liabilities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹160,054.0 Cr | 1.9% | 2% | 59.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,910.0 Cr | 5.4% | 3.2% | 20.4% | Stock Analytics | |
CIPLA | ₹125,540.0 Cr | 1.7% | 2% | 13.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,894.0 Cr | 2.8% | 2.3% | 22.8% | Stock Analytics | |
MANKIND PHARMA | ₹105,587.0 Cr | -0.6% | 7.9% | 6.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,110.0 Cr | 2.1% | -0.9% | -1.5% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 1.9% |
2% |
59.4% |
SENSEX | 1% |
4.3% |
8.9% |
You may also like the below Video Courses